Innovative PTCA Catheters Track Tortuous Anatomy

The Sapphire II Pro has a well-balanced subzero tapered tip with ultra-low profile for effortless entry through tight lesions. Other features include a proprietary XR balloon for high crossability and recrossability, without compromising durability and robustness.

The Sapphire NC Plus is a true non-compliant dilatation balloon featuring TiFo (tight fold) folding of the balloon material for enhanced crossability in the tightest lesions, Hydro-X coating for improved lubricity and passability, and an enhanced distal tip which allows for smooth lesion entry. Besides myocardial infusion, the Sapphire NC Plus is further indicated for dilatation of in-stent restenosis and post-delivery expansion of balloon expandable coronary stents.

“The Sapphire II Pro and Sapphire NC Plus are tried and proven technology in both the interventional coronary and interventional radiology markets outside the US. Entering the US market with our proven coronary dilatation catheters is a long overdue and logical step for our company,” said Scott Addonizio, Chief Operating Officer of OrbusNeich. “Since our establishment in 2005, we have delivered an extensive portfolio of unique products that have changed the lives of patients and their families around the world. Our focus will now include the US market and we are confident our product will be well received.”

PTCA is a minimally invasive procedure to open up blocked coronary arteries, allowing blood to circulate unobstructed to the heart muscle. The percutaneous procedure first places a guide wire and introducer. A diagnostic catheter is advanced through the introducer over the guide wire to reach the aorta, and the guide wire is removed. Fluoroscopy is then used to identify blockages in coronary arteries, and a balloon catheter is advanced to the blockage site to dilate the artery. A stent may be placed to keep the vessel open.

Related Links:
OrbusNeich